Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Total Non-Current Liabilities (2018 - 2026)

Alector's (ALEC) quarterly Total Non-Current Liabilities came in at $210.8 million in Q2 2026, down 25.72% year-over-year from $283.8 million in Q2 2025, and down 7.45% quarter-over-quarter from $227.8 million in Q1 2026.

Analysis

Alector (ALEC) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Total Non-Current Liabilities for 9 consecutive years, with $210.8 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 25.72% year-over-year to $210.8 million in Q2 2026; TTM through Jun 2026 was $210.8 million, a 25.72% decrease from a year earlier, with the FY2025 full-year figure at $260.9 million, down 23.34% from the prior year.
  • Total Non-Current Liabilities was $210.8 million for Q2 2026 at Alector, down from $227.8 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $686.8 million in Q1 2022 and troughed at $210.8 million in Q2 2026.
  • A 5-year average of $427.6 million and a median of $437.1 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities jumped 223.37% in 2022 and plunged 32.25% in 2025, its largest moves.
  • Over 5 years, Total Non-Current Liabilities stood at $572.4 million in 2022, then slipped by 15.05% to $486.3 million in 2023, then sank by 30.03% to $340.3 million in 2024, then fell by 23.34% to $260.9 million in 2025, then decreased by 19.19% to $210.8 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $210.8 million (Q2 2026), $227.8 million (Q1 2026), and $260.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 81.11 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 36.04 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 5.92 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 7.74 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 40.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 3.92 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 4.20 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 12.42 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 1.17 Bn
10 Alector 274.68 Mn 101.88 Mn - 210.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 210.80 Mn
Mar 31, 2026 227.76 Mn
Dec 31, 2025 260.85 Mn
Sep 30, 2025 276.13 Mn
Jun 30, 2025 283.80 Mn
Mar 31, 2025 312.30 Mn
Dec 31, 2024 340.27 Mn
Sep 30, 2024 395.86 Mn
Jun 30, 2024 418.93 Mn
Mar 31, 2024 455.21 Mn
Dec 31, 2023 486.30 Mn
Sep 30, 2023 508.94 Mn
Jun 30, 2023 511.53 Mn
Mar 31, 2023 564.43 Mn
Dec 31, 2022 572.45 Mn
Sep 30, 2022 583.70 Mn
Jun 30, 2022 600.92 Mn
Mar 31, 2022 686.76 Mn
Dec 31, 2021 513.78 Mn
Sep 30, 2021 518.18 Mn